{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:46:58Z","timestamp":1792633618929,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T00:00:00Z","timestamp":1544745600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004470","name":"Daewoong Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004470","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00417-018-4194-3","type":"journal-article","created":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T15:00:06Z","timestamp":1544799606000},"page":"331-338","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Effects of botulinum toxin type A on the treatment of dry eye disease and tear cytokines"],"prefix":"10.1007","volume":"257","author":[{"given":"Min Gyu","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon Hyung","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Woo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeoun Sook","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Kyu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6981-8941","authenticated-orcid":false,"given":"Jae Chan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,14]]},"reference":[{"key":"4194_CR1","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","volume":"15","author":"JP Craig","year":"2017","unstructured":"Craig JP, Nichols KK, Akpek EK, Caffery B, Dua HS, Joo CK, Liu Z, Nelson JD, Nichols JJ, Tsubota K, Stapleton F (2017) TFOS DEWS II definition and classification report. Ocul Surf 15:276\u2013283. \n                    https:\/\/doi.org\/10.1016\/j.jtos.2017.05.008","journal-title":"Ocul Surf"},{"key":"4194_CR2","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1097\/00006324-200308000-00009","volume":"80","author":"C Donald","year":"2003","unstructured":"Donald C, Hamilton L, Doughty M (2003) A quantitative assessment of the location and width of Marx\u2019s line along the marginal zone of the human eyelid. Optom Vis Sci 80:564\u2013572","journal-title":"Optom Vis Sci"},{"key":"4194_CR3","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","volume":"15","author":"AJ Bron","year":"2017","unstructured":"Bron AJ, de Paiva CS, Chauhan SK, Bonini S, Gabison EE, Jain S, Knop E, Markoulli M, Ogawa Y, Perez V, Uchino Y, Yokoi N, Zoukhri D, Sullivan DA (2017) TFOS DEWS II pathophysiology report. Ocul Surf 15:438\u2013510. \n                    https:\/\/doi.org\/10.1016\/j.jtos.2017.05.011","journal-title":"Ocul Surf"},{"key":"4194_CR4","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1136\/bjo.87.1.54","volume":"87","author":"J Horwath-Winter","year":"2003","unstructured":"Horwath-Winter J, Bergloeff J, Floegel I, Haller-Schober EM, Schmut O (2003) Botulinum toxin A treatment in patients suffering from blepharospasm and dry eye. Br J Ophthalmol 87:54\u201356","journal-title":"Br J Ophthalmol"},{"key":"4194_CR5","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/S0161-6420(80)35127-0","volume":"87","author":"AB Scott","year":"1980","unstructured":"Scott AB (1980) Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology 87:1044\u20131049","journal-title":"Ophthalmology"},{"key":"4194_CR6","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.ophtha.2005.03.021","volume":"112","author":"SA Kaltreider","year":"2005","unstructured":"Kaltreider SA, Kennedy RH, Woog JJ, Bradley EA, Custer PL, Meyer DR, American Academy of O, Ophthalmic Technology Assessment Committee Oculoplastics P (2005) Cosmetic oculofacial applications of botulinum toxin: a report by the American Academy of Ophthalmology. Ophthalmology 112:1159\u20131167. \n                    https:\/\/doi.org\/10.1016\/j.ophtha.2005.03.021","journal-title":"Ophthalmology"},{"key":"4194_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.4103\/0974-9233.63069","volume":"17","author":"P Kaynak-Hekimhan","year":"2010","unstructured":"Kaynak-Hekimhan P (2010) Noncosmetic periocular therapeutic applications of botulinum toxin. Middle East Afr J Ophthalmol 17:113\u2013120. \n                    https:\/\/doi.org\/10.4103\/0974-9233.63069","journal-title":"Middle East Afr J Ophthalmol"},{"key":"4194_CR8","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1097\/ICO.0b013e3181967006","volume":"28","author":"YS Chun","year":"2009","unstructured":"Chun YS, Kim JC (2009) Treatment of superior limbic keratoconjunctivitis with a large-diameter contact lens and botulium toxin A. Cornea 28:752\u2013758. \n                    https:\/\/doi.org\/10.1097\/ICO.0b013e3181967006","journal-title":"Cornea"},{"key":"4194_CR9","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1001\/archopht.118.5.615","volume":"118","author":"RM Schiffman","year":"2000","unstructured":"Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL (2000) Reliability and validity of the ocular surface disease index. Arch Ophthalmol 118:615\u2013621","journal-title":"Arch Ophthalmol"},{"key":"4194_CR10","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1016\/j.ophtha.2016.07.028","volume":"123","author":"EM Messmer","year":"2016","unstructured":"Messmer EM, von Lindenfels V, Garbe A, Kampik A (2016) Matrix metalloproteinase 9 testing in dry eye disease using a commercially available point-of-care immunoassay. Ophthalmology 123:2300\u20132308. \n                    https:\/\/doi.org\/10.1016\/j.ophtha.2016.07.028","journal-title":"Ophthalmology"},{"key":"4194_CR11","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/j.ophtha.2015.04.010","volume":"122","author":"P Chhadva","year":"2015","unstructured":"Chhadva P, Lee T, Sarantopoulos CD, Hackam AS, McClellan AL, Felix ER, Levitt RC, Galor A (2015) Human tear serotonin levels correlate with symptoms and signs of dry eye. Ophthalmology 122:1675\u20131680. \n                    https:\/\/doi.org\/10.1016\/j.ophtha.2015.04.010","journal-title":"Ophthalmology"},{"key":"4194_CR12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1177\/112067219400400305","volume":"4","author":"XD Martin","year":"1994","unstructured":"Martin XD, Brennan MC (1994) Serotonin in human tears. Eur J Ophthalmol 4:159\u2013165","journal-title":"Eur J Ophthalmol"},{"key":"4194_CR13","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S0002-9394(99)00408-0","volume":"129","author":"S Sahlin","year":"2000","unstructured":"Sahlin S, Chen E, Kaugesaar T, Almqvist H, Kjellberg K, Lennerstrand G (2000) Effect of eyelid botulinum toxin injection on lacrimal drainage. Am J Ophthalmol 129:481\u2013486","journal-title":"Am J Ophthalmol"},{"key":"4194_CR14","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s40123-017-0079-5","volume":"6","author":"SM Fouda","year":"2017","unstructured":"Fouda SM, Mattout HK (2017) Comparison between botulinum toxin a injection and lacrimal punctal plugs for the control of post-LASIK dry eye manifestations: a prospective study. Ophthalmol Therapy 6:167\u2013174. \n                    https:\/\/doi.org\/10.1007\/s40123-017-0079-5","journal-title":"Ophthalmol Therapy"},{"key":"4194_CR15","doi-asserted-by":"publisher","first-page":"e132","DOI":"10.1111\/aos.13140","volume":"95","author":"JC Serna-Ojeda","year":"2017","unstructured":"Serna-Ojeda JC, Nava-Castaneda A (2017) Paralysis of the orbicularis muscle of the eye using botulinum toxin type A in the treatment for dry eye. Acta Ophthalmol 95:e132\u2013e137. \n                    https:\/\/doi.org\/10.1111\/aos.13140","journal-title":"Acta Ophthalmol"},{"key":"4194_CR16","first-page":"1842","volume":"24","author":"H Spiera","year":"1997","unstructured":"Spiera H, Asbell PA, Simpson DM (1997) Botulinum toxin increases tearing in patients with Sjogren\u2019s syndrome: a preliminary report. J Rheumatol 24:1842\u20131843","journal-title":"J Rheumatol"},{"key":"4194_CR17","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s10384-016-0469-6","volume":"60","author":"Y Isshiki","year":"2016","unstructured":"Isshiki Y, Ishikawa H, Mimura O (2016) Changes in ocular higher-order aberrations following botulinum toxin treatment in patients with blepharospasm : BTX improves dry eye in patients with BEB. Jpn J Ophthalmol 60:486\u2013491. \n                    https:\/\/doi.org\/10.1007\/s10384-016-0469-6","journal-title":"Jpn J Ophthalmol"},{"key":"4194_CR18","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1001\/jamaophthalmol.2013.6243","volume":"132","author":"MC Ho","year":"2014","unstructured":"Ho MC, Hsu WC, Hsieh YT (2014) Botulinum toxin type A injection for lateral canthal rhytids: effect on tear film stability and tear production. JAMA Ophthalmol 132:332\u2013337. \n                    https:\/\/doi.org\/10.1001\/jamaophthalmol.2013.6243","journal-title":"JAMA Ophthalmol"},{"key":"4194_CR19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1001\/jamaophthalmol.2013.561","volume":"131","author":"R Sambursky","year":"2013","unstructured":"Sambursky R, Davitt WF 3rd, Latkany R, Tauber S, Starr C, Friedberg M, Dirks MS, McDonald M (2013) Sensitivity and specificity of a point-of-care matrix metalloproteinase 9 immunoassay for diagnosing inflammation related to dry eye. JAMA Ophthalmol 131:24\u201328. \n                    https:\/\/doi.org\/10.1001\/jamaophthalmol.2013.561","journal-title":"JAMA Ophthalmol"},{"key":"4194_CR20","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1136\/bjophthalmol-2014-306057","volume":"99","author":"A Galor","year":"2015","unstructured":"Galor A, Zlotcavitch L, Walter SD, Felix ER, Feuer W, Martin ER, Margolis TP, Sarantopoulos KD, Levitt RC (2015) Dry eye symptom severity and persistence are associated with symptoms of neuropathic pain. Br J Ophthalmol 99:665\u2013668. \n                    https:\/\/doi.org\/10.1136\/bjophthalmol-2014-306057","journal-title":"Br J Ophthalmol"},{"key":"4194_CR21","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1385\/MN:30:2:117","volume":"30","author":"C Sommer","year":"2004","unstructured":"Sommer C (2004) Serotonin in pain and analgesia: actions in the periphery. Mol Neurobiol 30:117\u2013125. \n                    https:\/\/doi.org\/10.1385\/MN:30:2:117","journal-title":"Mol Neurobiol"},{"key":"4194_CR22","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1097\/FBP.0b013e328349aae4","volume":"22","author":"L Bardin","year":"2011","unstructured":"Bardin L (2011) The complex role of serotonin and 5-HT receptors in chronic pain. Behav Pharmacol 22:390\u2013404. \n                    https:\/\/doi.org\/10.1097\/FBP.0b013e328349aae4","journal-title":"Behav Pharmacol"},{"key":"4194_CR23","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.neuroscience.2005.05.046","volume":"134","author":"G Moalem","year":"2005","unstructured":"Moalem G, Grafe P, Tracey DJ (2005) Chemical mediators enhance the excitability of unmyelinated sensory axons in normal and injured peripheral nerve of the rat. Neuroscience 134:1399\u20131411. \n                    https:\/\/doi.org\/10.1016\/j.neuroscience.2005.05.046","journal-title":"Neuroscience"},{"key":"4194_CR24","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s10194-017-0744-z","volume":"18","author":"G Sandrini","year":"2017","unstructured":"Sandrini G, De Icco R, Tassorelli C, Smania N, Tamburin S (2017) Botulinum neurotoxin type A for the treatment of pain: not just in migraine and trigeminal neuralgia. J Headache Pain 18:38. \n                    https:\/\/doi.org\/10.1186\/s10194-017-0744-z","journal-title":"J Headache Pain"},{"key":"4194_CR25","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1177\/0333102414527648","volume":"34","author":"R Burstein","year":"2014","unstructured":"Burstein R, Zhang X, Levy D, Aoki KR, Brin MF (2014) Selective inhibition of meningeal nociceptors by botulinum neurotoxin type A: therapeutic implications for migraine and other pains. Cephalalgia 34:853\u2013869. \n                    https:\/\/doi.org\/10.1177\/0333102414527648","journal-title":"Cephalalgia"},{"key":"4194_CR26","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3109\/01676830.2011.648802","volume":"31","author":"R Bourkiza","year":"2012","unstructured":"Bourkiza R, Lee V (2012) A review of the complications of lacrimal occlusion with punctal and canalicular plugs. Orbit 31:86\u201393. \n                    https:\/\/doi.org\/10.3109\/01676830.2011.648802","journal-title":"Orbit"},{"key":"4194_CR27","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jtos.2015.10.004","volume":"14","author":"NL Lanza","year":"2016","unstructured":"Lanza NL, Valenzuela F, Perez VL, Galor A (2016) The matrix metallopreteinase 9 point-or-care test in dry eye. Ocul Surf 14:189\u2013195. \n                    https:\/\/doi.org\/10.1016\/j.jtos.2015.10.004","journal-title":"Ocul Surf"},{"key":"4194_CR28","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1136\/bjo.81.10.824","volume":"81","author":"NJ Haeringen van","year":"1997","unstructured":"van Haeringen NJ (1997) Aging and the lacrimal system. Br J Ophthalmol 81:824\u2013826","journal-title":"Br J Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-018-4194-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-018-4194-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-018-4194-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T19:10:18Z","timestamp":1576264218000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-018-4194-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,14]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["4194"],"URL":"https:\/\/doi.org\/10.1007\/s00417-018-4194-3","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,14]]},"assertion":[{"value":"3 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Jae Chan Kim received research grants from Daewoong Pharmaceutical. Min Gyu Choi, Joon Hyung Yeo, Jeong Woo Kang, Yeoun Sook Chun, and Jeong Kyu Lee declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with ethical standards of the institutional and\/or national research committee (Chung-Ang University Hospital Institutional Review Board) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}